Recurrent Malignant Endocrine Neoplasm

1 clinical trials · Condition

Record	Firm	Date
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors (NCT03420963)	M.D. Anderson Cancer Center	2018-08-31

Every clearance here is in the API, with alerts when new ones post.